The Society of Hospital Pharmacists of Australia

The latest issue of Pharmacy GRIT provides a snapshot of a profession at a crossroads, as a year of once-in-a-generation upheaval gives way to one of hope and promise.

‘We have called for this expert pharmacist presence for some time and look forward to partnering with government to ensure safe and effective implementation,’ says SHPA Chief Executive Kristin Michaels, as the Aged Care Royal Commission final report is tabled.

First ever systematic review and meta-analysis of the impact of dispensing errors interventions, and an inspiring oration from 2020 Fred J Boyd recipient Prof Jeff Hughes, lead a powerful new issue of JPPR.

SHPA is proudly celebrating the efforts of hospital pharmacists and technicians across the country following yesterday’s successful Day 1 of Australia’s COVID-19 vaccination program.

More than four-fifths of Australian pharmacy students wish to undertake hospital pharmacy residency, while hospitals remain the workplace destination of choice according to latest data.

Australia’s hospital pharmacists are preparing for their central role in the safe and secure administration of COVID-19 vaccinations, with less than one month until the first scheduled doses, supported by SHPA’s new resources, education and a member forum.

SHPA is part of an eight-member consortium led by NPS MedicineWise, aiming to improve the use of biological disease-modifying anti-rheumatic drugs (bDMARDs) for inflammatory arthritis.

SHPA's 'Standard of Practice in Oncology and Haematology for Pharmacy Services' appears in the latest issue of JPPR, released this week, at a time of rapidly increasing and broadening use of oncology and haematology medications in Australia.

SHPA has released a practice update to support safe, immediate use of a powerful opioid toxicity antidote, now more readily available through the Australian Government’s ‘Take home naloxone’ pilot program.

We look back on a year of challenges, resilience and strong growth in our 2020 Annual Report video, as members renewed in force and embraced a flexible CPD Calendar.

SHPA members are progressive advocates for clinical excellence, committed to evidence-based practice and passionate about patient care.

Please note the SHPA office is currently closed with staff working remotely. Until further notice, the SHPA Secretariat landline will not be in use, please direct enquiries to shpa@shpa.org.au or directly to relevant SHPA staff via email or mobile.

Latest News

More stories

News

Survey: 2021 Medicine Shortages in Pharmacy

Building on SHPA’s leading research and advocacy from 2017, the broader pharmacy profession has united behind a new survey to capture how medicines shortages are affecting hospital and community pharmacies in Australia, measures to mitigate their impact and the resulting negative effects on patient care.

News

New Standard Therapeutic Goods Order 106 – Data Matrix codes and Serialisation of Medicines

A new standard Therapeutic Goods (Medicines – Standard for Serialisation and Data Matrix Codes) (TGO 106) Order 2021 has been registered on the Federal Register of Legislation and will commence on 1 January 2023.

News

bDMARDs: Rheumatology resources now available

NPS MedicineWise is leading a consortium of nine organisations, including SHPA, in a three-year project funded by the Australian Government Department of Health. The program aims to support safe and wise therapeutic decisions about bDMARDs and other specialised medicines across a range of rheumatology, dermatology, gastroenterology, immunology and oncology indications.

Upcoming CPD Events

View All

Apr

24

Seminar

ClinCATⓇ Virtual (April 2021)

Apr

24

Seminar

Foundation Seminar in Palliative Care

May

5

Webinar

SA/NT Branch | Oral chemotherapy agents: What every pharmacist should know

Explore SHPA